CAD 7.15
(1.85%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 213.12 Million USD | -28.44% |
2022 | 297.8 Million USD | 40.35% |
2021 | 212.18 Million USD | 115.83% |
2020 | 98.31 Million USD | -63.75% |
2019 | 271.19 Million USD | 403.07% |
2018 | 53.9 Million CAD | 349.5% |
2017 | 11.99 Million CAD | 849.64% |
2016 | 1.26 Million CAD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 209.4 Million USD | -1.74% |
2024 Q2 | 207.63 Million USD | -0.85% |
2023 FY | 213.12 Million USD | -28.44% |
2023 Q2 | 252.8 Million USD | -15.05% |
2023 Q4 | 213.12 Million USD | -7.3% |
2023 Q1 | 297.6 Million USD | -0.07% |
2023 Q3 | 229.89 Million USD | -9.06% |
2022 Q4 | 297.8 Million USD | -1.14% |
2022 FY | 297.8 Million USD | 40.35% |
2022 Q1 | 236.42 Million USD | 11.42% |
2022 Q2 | 270.2 Million USD | 14.29% |
2022 Q3 | 301.23 Million USD | 11.48% |
2021 Q1 | 103.91 Million USD | 5.69% |
2021 FY | 212.18 Million USD | 115.83% |
2021 Q4 | 212.18 Million USD | 58.5% |
2021 Q3 | 133.87 Million USD | 18.86% |
2021 Q2 | 112.62 Million USD | 8.39% |
2020 FY | 98.31 Million USD | -63.75% |
2020 Q4 | 98.31 Million USD | -59.04% |
2020 Q3 | 240.03 Million USD | -4.85% |
2020 Q2 | 252.26 Million USD | -6.26% |
2020 Q1 | 269.11 Million USD | -0.77% |
2019 Q2 | 134.64 Million USD | 98.88% |
2019 Q4 | 271.19 Million USD | 31.16% |
2019 Q3 | 206.75 Million USD | 53.56% |
2019 Q1 | 67.7 Million CAD | 25.59% |
2019 FY | 271.19 Million USD | 403.07% |
2018 Q2 | 23.56 Million CAD | 0.0% |
2018 Q4 | 53.9 Million CAD | 29.53% |
2018 FY | 53.9 Million CAD | 349.5% |
2018 Q1 | - CAD | -100.0% |
2018 Q3 | 41.61 Million CAD | 76.62% |
2017 Q4 | 11.99 Million CAD | 0.0% |
2017 Q1 | - USD | -100.0% |
2017 Q3 | - CAD | 0.0% |
2017 FY | 11.99 Million CAD | 849.64% |
2016 Q4 | 0.55 CAD | 0.0% |
2016 FY | 1.26 Million CAD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Aion Therapeutic Inc. | -197.38 CAD | 107974565.498% |
Ayurcann Holdings Corp. | 5.36 Million CAD | -3874.192% |
Blueberries Medical Corp. | 260.7 Thousand CAD | -81646.628% |
The BC Bud Corporation | 487.25 Thousand CAD | -43639.084% |
BioNxt Solutions Inc. | -282.56 Thousand CAD | 75524.155% |
CordovaCann Corp. | 919.48 Thousand CAD | -23078.293% |
Christina Lake Cannabis Corp. | 5.65 Million CAD | -3669.024% |
Captor Capital Corp. | 1.48 Million CAD | -14240.931% |
City View Green Holdings Inc. | -3503.00 CAD | 6084028.062% |
1CM Inc. | 4.2 Million CAD | -4968.876% |
Global Hemp Group Inc. | - CAD | -Infinity% |
Greenway Greenhouse Cannabis Corporation | 2.01 Million CAD | -10457.023% |
IM Cannabis Corp. | 10.91 Million CAD | -1853.079% |
Lobe Sciences Ltd. | 16.97 Thousand CAD | -1255097.597% |
Maple Leaf Green World Inc. | - CAD | -Infinity% |
Mountain Valley MD Holdings Inc. | 1.21 Million CAD | -17397.537% |
Nextleaf Solutions Ltd. | 2.24 Million CAD | -9398.427% |
Ovation Science Inc. | 17.24 Thousand CAD | -1235879.818% |
Pharmadrug Inc. | - CAD | -Infinity% |
Captiva Verde Wellness Corp. | - CAD | -Infinity% |
RAMM Pharma Corp. | 3.37 Million CAD | -6214.742% |
RIV Capital Inc. | 13.72 Million CAD | -1452.901% |
Revive Therapeutics Ltd. | - CAD | -Infinity% |
Red White & Bloom Brands Inc. | 19.46 Million CAD | -995.05% |
SLANG Worldwide Inc. | 6.17 Million CAD | -3353.36% |
1933 Industries Inc. | 2.6 Million CAD | -8079.689% |
Red Light Holland Corp. | 874.26 Thousand CAD | -24277.048% |
Top Strike Resources Corp. | 2.03 Million CAD | -10370.798% |
Xebra Brands Ltd. | - CAD | -Infinity% |
Adastra Holdings Ltd. | 4.29 Million CAD | -4867.282% |